Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-29 @ 12:50 AM
Study NCT ID:
NCT01174160
Status:
COMPLETED
Last Update Posted:
2015-12-15
First Post:
2010-07-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Efficacy and Safety of Vernakalant Hydrochloride (MK-6621) in Patients With Atrial Fibrillation (MK-6621-010 AM4)
Sponsor:
Advanz Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-30
First Submit QC Date:
None
Study First Post Date:
2010-08-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-09
Results First Submit QC Date:
None
Results First Post Date:
2015-12-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-11-09
Last Update Post Date:
2015-12-15
Last Update Post Date Type:
ESTIMATED